Page 83 - CIBEROBN2016-ENG
P. 83
• Study the relationship between cardiovascular risk factors, diet and drug treatments on erectile function.
• Relationship between nutritional factors and lifestyle with plasma homocysteine concentrations.
Most relevant scientific articles
• Estruch R., Martínez-González M.A., Corella D., Salas-Salvadó J., Fito M., Chiva-Blanch G. et
al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: A prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. The Lancet Diabetes and Endocrinology. 2016.
• Sala-Vila A., Díaz-López A., Valls-Pedret C., Cofan M., García-Layana A., Lamuela-Raventós R.-M. et al. Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial. JAMA Ophthalmology. 2016;134(10):1142-1149.
• Sala-Vila A., Guasch-Ferre M., Hu F.B., Sánchez-Tainta A., Bullo M., Serra-Mir M. et al. Dietary α-linolenic acid, marine ω-3 fatty acids, and mortality in a population with high fish consumption: Findings from the PREvención con DIeta MEDiterránea (PREDIMED) Study. Journal of the American Heart Association. 2016;5(1).
• Tresserra-Rimbau A., Guasch-Ferre M., Salas-Salvadó J., Toledo E., Corella D., Castaner O. et al. Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk. Journal of Nutrition. 2016;146(4):767-777.
• Downer M.K., Gea A., Stampfer M., Sánchez-Tainta A., Corella D., Salas-Salvadó J. et al. Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: The PREDIMED randomized trial. International Journal of Behavioral Nutrition and Physical Activity. 2016;13(1).
Hightlights
• Achievement of the recruitment objectives of the PREDIMEDplus Study.
• Guide to high-intensity lipid-lowering therapy in high-risk cardiovascular patients.
• Guide for the diagnosis and treatment of abdominal aortic aneurysm.
• Guide of the Spanish Society of Arteriosclerosis on indications of PCSK9 inhibitors.
• Guide on pharmacological treatment of atherogenic dyslipidemia with statin-fenofibrate combination
therapy.
• Guideline on the management of dyslipidemia in patients with impaired glucose metabolism.
OBN
Research groups 83


































































































   81   82   83   84   85